234 related articles for article (PubMed ID: 32236588)
21. Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway.
Zhao Y; Cai J; Shi K; Li H; Du J; Hu D; Liu Z; Wang W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880579
[TBL] [Abstract][Full Text] [Related]
22. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
Meng G; Wang W; Chai K; Yang S; Li F; Jiang K
Int J Oncol; 2015 Mar; 46(3):1007-17. PubMed ID: 25573072
[TBL] [Abstract][Full Text] [Related]
23. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
[TBL] [Abstract][Full Text] [Related]
24. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
25. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
[TBL] [Abstract][Full Text] [Related]
27. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
28. Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity.
Zhu J; Wang H; Chen F; Lv H; Xu Z; Fu J; Hou Y; Xu Y; Pi J
Toxicol Appl Pharmacol; 2018 Nov; 358():1-9. PubMed ID: 30196066
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L
Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592
[TBL] [Abstract][Full Text] [Related]
30. TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53/MDM2-dependent mechanism, a quantitative proteomics study.
Lin Y; Xie G; Xia J; Su D; Liu J; Jiang F; Xu Y
Biochim Biophys Acta; 2016 Feb; 1864(2):204-10. PubMed ID: 26549658
[TBL] [Abstract][Full Text] [Related]
31. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
32. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
[TBL] [Abstract][Full Text] [Related]
33. Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells.
Yan X; Ke XX; Zhao H; Huang M; Hu R; Cui H
Mol Med Rep; 2015 Feb; 11(2):791-6. PubMed ID: 25354591
[TBL] [Abstract][Full Text] [Related]
34. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
35. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
36. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
37. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
38. A new PICTure of nucleolar stress.
Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
[TBL] [Abstract][Full Text] [Related]
39. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
[TBL] [Abstract][Full Text] [Related]
40. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.
Li M; Zhang X; Zhou WJ; Chen YH; Liu H; Liu L; Yang CM; Qan WB
Acta Pharmacol Sin; 2013 Dec; 34(12):1545-53. PubMed ID: 24241349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
